Members

Full Professor at UC3M and Senior Researcher at the IiSGM, leading BSEL-CMBIES group.   Telecommunications Engineer and PhD in Bioengineering from the Universidad Politecnica de  Madrid, with experience  in medical imaging  and a successful track record of inventions and scientific contributions in preclinical imaging. He has participated in the IMI PreDiCT-TB project (GA115337) and he is the coordinator of the IMI ERA4TB project (GA853989), the largest European research project to develop treatments and technologies  to fight  tuberculosis.

ORCID: 0000-0001-9200-361X

Distinguished Researcher at UC3M  since March 2021. Ph.D. in Biological Sciences (1991). With 27 years of experience in Drug Discovery, holding 2 patents, and currently overseeing 5 compounds in various phases of clinical development. Engaged in numerous projects aimed at identifying and advancing new antimicrobial agents. Served as Coordinator for GSK in European projects (ORCHID,PredicTB, ERA4TB) and the international TBDA (Tuberculosis Drug Accelerator). Initiated and coordinated GSK’s activities focused on Covid-19 (diagnosis, support for clinical trials, and Drug Discovery) throughout 2020. He has also been helping to establish the School of Biomedical Sciences, expected to open in 2024 at UC3M. ORCID: 0000-0003-2493-4118.

Scientific Advisor for Drug Discovery at UC3M. Ph.D. in Biological Sciences from the University of Barcelona (1995), with a 24-year research career in the pharmaceutical industry. Specializing in Microbiology, Pharmacology, Pharmacokinetics, and the Metabolism of anti-infectives, he served as the head of GSK’s Level 3 Biosafety facilities for in vivo work in Spain for 6 years. Subsequently, he became the Head of the Department of Pharmacokinetics, Pharmacodynamics, and Pharmacology. He has actively participated in numerous projects for the identification and development of antimicrobials and represented GSK in various international projects (GSK-MMV Support Group, PreDiCT-TB, AnTBiotic, ERA4TB). He has also been helping to establish the School of Biomedical Sciences, expected to open in 2024 at UC3M. With extensive experience in translational pharmacology, he is a co-author of over 65 publications in scientific journals. 

ORCID ID: 0000-0002-6672-551X

Project Manager and Researcher. Chemical Engineer, MSc. in Bioinformatics and Biostatistic and Ph.D. in Chemical Engineering. Extensive experience in data analysis, development of computational models, and algorithms for the analysis of micro and nanometric images in biotechnological applications. He has actively participated in more than 10 national and European projects, contributing to both research and management tasks (including the management of 4 projects funded by the Community of Madrid).

 ORCID: 0000-0002-0553-3370

Project Manager and Researcher. Physicist, MSc. in Computational Biomedical Engineering from the University of Eastern Finland , and Ph.D. in Biomedical Engineering in the field of Nuclear Medicine. Extensive experience in digital signal processing, medical imaging reconstruction, electronics, and laser material processing. He worked for 4 years as software developer for the company Eemagine Medical Imaging Solutions in Berlin. His main areas of interest are medical imaging and EEG.He currently participates in one national project and two European projects, contributing to both research and management tasks.

 ORCID: 0000-0003-0575-0671.